Angiotensin II receptor antagonist and statin

This page covers all Angiotensin II receptor antagonist and statin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin II receptor and HMG-CoA reductase, AT1 receptor and HMG-CoA reductase.

Targets

Angiotensin II receptor and HMG-CoA reductase · AT1 receptor and HMG-CoA reductase

Phase 3 pipeline (2)

• valsartan + simvastatin · Novartis · Cardiovascular
  Valsartan is an angiotensin II receptor antagonist that blocks the effects of angiotensin II, a potent vasoconstrictor, thereby lowering blood pressure. Simvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis, thereby lowering cholesterol levels.
• Valsartan and simvastatin · Novartis · Cardiovascular
  Valsartan is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure. Simvastatin is a statin that inhibits HMG-CoA reductase to reduce cholesterol production in the liver.